Viewing nowPioglitazone Tablet (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Cosmax Pharma Co., Ltd.

MFDS item code 201901271 · Approved 2019.02.28 · Insurance code 055100860
Improvement of Type 2 Diabetes (blood sugar control)
This drug is used to help control blood sugar levels in patients with Type 2 diabetes. It can be administered alone or in combination with sulfonylureas, metformin, or insulin when other oral hypoglycemic agents are insufficient. Additionally, nutritional counseling, weight loss, and exercise therapy should be conducted in conjunction with Type 2 diabetes patients. Such dietary and exercise therapies are very important for enhancing and maintaining the effects of drug therapy. This drug helps improve blood sugar control.
This drug is administered orally once a day, regardless of meals. It can be started at a dose of 15 mg once daily as monotherapy, and if there is insufficient effect, the dose can be increased to 30 mg once daily. When used in combination with sulfonylureas, metformin, or insulin, the initial dose is also 15 mg once daily, and the maximum recommended dose should not exceed 30 mg once daily.
There is no experience using in children under 18 years; therefore, administration is not recommended.
This drug is used for the treatment of Type 2 diabetes and helps improve insulin resistance and control blood sugar levels. During the use of this drug, caution should be taken regarding heart function. In some patients, this drug may induce or worsen heart failure, so if symptoms such as weight change, shortness of breath, or swelling occur, immediate consultation with a physician is necessary. Patients with heart failure or a history of heart failure should not take this drug. Additionally, this drug may cause fluid retention that can stress the heart, so it should be used with increased caution in patients with cardiovascular disease. During the use of this drug, if symptoms related to the bladder, such as hematuria, urinary disorders, or urgency, appear, the physician should be informed immediately to rule out bladder cancer. This drug should not be administered to patients with severe liver or kidney impairment, and regular liver function and kidney function tests should be performed. Women who are pregnant or may become pregnant should not take this drug, and premenopausal women should use appropriate contraceptive methods due to the risk of ovulation stimulation leading to pregnancy. This drug may increase the risk of hypoglycemia when combined with other hypoglycemic agents or insulin, so dose adjustments may be necessary when used in combination. Furthermore, this drug can cause weight gain and edema, so careful monitoring of weight changes and edema symptoms is advised. Elderly patients or those with decreased kidney and liver function should exercise additional caution when using this drug, and regular health checks are necessary. In case of overdose, even if special symptoms are absent, immediate consultation with healthcare professionals for appropriate action is advised. This drug has not been shown to be safe and effective in children; therefore, it should not be used in this population.
Congestive heart failure, symptoms and signs of heart failure (including excessive and rapid weight change, shortness of breath, swelling), worsening heart failure, myocardial infarction, stroke, serious cardiac adverse reactions, gross hematuria, urinary disorders, urgency, bladder cancer, liver failure, liver dysfunction (including jaundice symptoms), fatal and non-fatal liver failure, severe edema, hospitalization due to hypoglycemia, severe neurological symptoms (headache, seizures, confusion, visual disturbances
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a tightly closed container protected from light. It should be kept in a cool place away from high humidity at temperatures between 15 and 30 degrees Celsius, preferably around 25 degrees.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Cosmax Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.